Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)1
In this study, we attempt to target both the urokinase plasminogen activator and the mitogen-activated protein kinase pathway in acute myeloid leukemia (AML) cell lines and primary AML blasts using PrAgU2/LF, a urokinase-activated anthrax lethal toxin. PrAgU2/LF was cytotoxic to five out of nine AML...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Neoplasia Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630967/ |